Author: Healio ophthalmology

Ocugen, Histogenics to merge

Ocugen and Histogenics have entered into a definitive merger agreement that will result in a combined publicly traded, clinical-stage biopharmaceutical company operating under the Ocugen name, according to a press release.Under the merger agreement, Oc…